Podcasts about GE Healthcare

On this episode of MedAxiom HeartTalk, host Melanie Lawson, MS sits down with April Mann, MBA, CNMT, NCT, RT(N), MASNC, FSNMMI-TS, stakeholder engagement lead at GE HealthCare. Together, they discuss a collaborative two-part webinar series establishing shared cardiac PET services. Learn about operational, technical, and business case considerations for building a sustainable program. Expert insights will guide administrators and leadership through governance, accountability, and overcoming common challenges in shared service models.

Brent Lavin, principal at Ironwood Medtech Partners, shares how he helps early-stage medtech companies build commercial strategies from concept through commercialization and exit. Brent reflects on his path from electrical engineer to launch expert, including lessons learned after seeing how overbuilt product features can complicate V&V and FDA review, and why founders must make early decisions with the end in mind. He discusses common startup pitfalls, the importance of pairing technical innovation with a strong commercial plan, and practical leadership insights on hiring “the right seat,” delegation, and setting clear standards while allowing teams flexibility in execution.    Guest links: https://www.linkedin.com/in/brent-lavin/ Charity supported: Save the Children Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host & Editor: Lindsey Dinneen Producer: Velentium Medical   EPISODE TRANSCRIPT Episode 084 - Brent Lavin [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I'm delighted to welcome as my guest Brent Lavin. Brent is currently principal at Ironwood Medtech Partners, where they help build the commercial logic into medtech startup innovation from concept through commercialization and exit. As an engineer turned launch expert, Brent has helped commercialize 20+ 510K PMA products and led the buy side of four M&A transactions, so he knows what buyers value beyond the science. With a diverse background from GE Healthcare to C.R. Bard to BD to now leading Ironwood Medtech Partners, he thrives on helping early-stage companies navigate the complex healthcare landscape and build successful companies. All right. Brent, welcome to the show. So glad to have you here today. [00:01:39] Brent Lavin: Yeah, great to be here. Thanks so much for the invite. I appreciate it. [00:01:42] Lindsey Dinneen: Absolutely. Well, I'd love if you would start by just sharing a little bit about yourself, your background, and what led you to medtech? [00:01:50] Brent Lavin: Yeah. So, I'm Brent Lavin. I live here in Phoenix, Arizona. I've recently founded Ironwood Medtech Partners, which is my company helping early-stage medtech. But I spent nearly 20 years in strategic medtech, and so I originally came to the industry through the engineering function. I was an electrical engineer in product development and innovation. And after three or four years of that, decided I wanna move over into what was, what is traditionally product management. And so, through my MBA program and then starting with GE Healthcare, I've spent the last 20 years at this intersection of R&D innovation, strategy, business development, and marketing. And so, really great run. Have been on the buy side of several M&A transactions, and I try to bring all of that experience to the early stage so that, you know, companies as they start out, can be building for the future. And so, it's been a great journey in medtech, and I've loved it so far. [00:02:46] Lindsey Dinneen: Yeah. Okay, so, so many things to ask about, but I'll, I'll start here. So, all right, so you're sa- you know, as you, you mentioned building towards the future and especially with these young startups that might not have a lot of experience in that particular kind of environment, or they're leading their company for the first time. What are some of the things that you see that maybe are pitfalls to avoid? Just, just like maybe some of the things that you've seen startups struggle with a little bit, and how can we help them mitigate those risks? [00:03:17] Brent Lavin: Yeah, there is a lot there, but let me just start by saying there is no linear path, and it is a very circular, ongoing process as you work through those early stages. And we call it the fuzzy front end for a very good reason. And sometimes you need to go down paths to realize that's not the right path, and you need to be comfortable with that. But at the end of the day, one of my goals is to help early-stage companies build with the end in mind because whether you acknowledge it or not, you're making decisions today that are ultimately gonna affect how you commercialize in the future. And so at least being able to make those decisions with your eyes wide open and understanding the trade-offs that are going on. And so for somebody that's been at the very end of that process, I, I can help inform, you know, those early stages so that you make priority decisions and trade-offs, you know, with full-scale information. [00:04:17] Lindsey Dinneen: Okay. Yeah. Well, I, I love the fact that you highlighted it's not a linear path, and there are a lot of things that go into, of course, the success of a startup. I'm wondering, in, in your role now, what are some of the areas which you see successful startups really thrive in as they're working with, with somebody like you to help make them successful from the start? [00:04:42] Brent Lavin: Yeah. Thanks for that question. I love working with early-stage founders that are passionate about their technology but especially those that realize where they may need to supplement their technical background with more of a commercial mindset. And so the, the people that work, that I work best with, are open to inputs and consideration of other options as they go through that process because you know, the, the famous saying, "What got you here is not what's going to get you there." And so while technical innovation is, is key that may not lead to an acquisition if you can't tie it to a strong commercial plan. [00:05:22] Lindsey Dinneen: Mm, mm-hmm. Yeah, so actually this is an area that I'm very curious about even in your own journey is, so you started off with that technical background as an electrical engineer, and I'd love to hear a little bit more about that as well. But maybe if you don't mind sharing a little bit about the transition or the learning process of going from that as a really good base to also being able to understand the full life cycle and how to make something succeed. [00:05:47] Brent Lavin: Yeah. Well, let me kind of go back to those engineering days and talk a little bit about how I made that pivot from engineering into product management. And to be honest, I didn't know exactly what I was doing at the time, but a-as an engineer, I was working with a product development team where we were creating a project. I was at a s- a contract design manufacturing company, and we were working with an outside company that owned a patent for a laboratory blood culturing instrument. And so we were their engineering partner, and what I saw firsthand was unfortunately, this customer at the time did not have full insight into the workflow and how the device was used in practice. And so as an engineering team, we frankly overbuilt many options into the product in order to try to s-satisfy everybody. And that seemed attractive at the time, but ultimately when we got to V&V, verification validation, and the FDA review process, it was a real struggle to get this on market. Now we ultimately did, but the epiphany for me was, I am really good at understanding engineering trade-offs and working with engineering teams to go through the process of evaluating different options. But I also really like working with customers and understanding what moves the needle and what's the difference between a nice to have and a need to have. And so, it was that kind of experience firsthand that led me to say, "I wanna operate at this intersection and really operate in both sides of that equation." And so ultimately I decided I needed to get an MBA in order to do that. So I left a, a good paying engineering job right after I got married and we moved to Madison and I got my MBA and then, you know, that ultimately led to GE Healthcare and, and then, you know, continued career in medtech. So thanks for asking that question. [00:07:43] Lindsey Dinneen: Yeah. Well, okay, so your leadership journey, of course, has, has evolved over time as, as often happens, and, and you've gone from leadership positions within other organizations to, of course, now leading your own. And I'd love if you'd just share a little bit about that journey of, of growth and discovery, maybe some, you know, lessons learned along the way. [00:08:06] Brent Lavin: Yeah. So, let's talk a little bit about kind of my formal leadership in the, you know, corporate structure and organization. I would say, we were chatting beforehand that, you know, I really moved through slowly at the beginning of my leadership from one person to three people to five people. And as an ambitious person, I always felt like that was too slow. And so, but I think it was those foundational aspects of working very closely one-on-one with people, hiring, deciding who to hire, selection, onboarding having crucial conversations about performance management and how to put people in the right seat to be successful, all occurred when my leadership span was frankly smaller than probably I was hoping it would be. But at the proper time, my leadership expanded very quickly from five to seven and ultimately 22 people within about an 18-month period. And if I had not had those slow steps along the way, I don't think I would've been ready for that and I, I would've struggled. And so, even though my ambition was high, the pace was just right in order to be successful in that. Now, to your second part of the question of, you know, how do you then transition to this, this new role? That has been a learning experience, and I'm not sure I have it mastered but it is all about influence. And so, you know, leadership, even in a formal organization, while you can be connected on the org chart, ultimately boils down to influence. And so my goal is to influence early-stage companies to understand the trade-offs that they're making and hopefully help them chart the best path forward for the goal that they have, you know, individually. Every company is built differently, and so I try to channel what their goals are into my recommendations. [00:10:02] Lindsey Dinneen: Absolutely. So you mentioned something that is brought up often, but I think it's a concept that would be worth diving into, and that's the concept of the right seat, and I would love if you would share a little bit more about your philosophy behind that and how, as a leader too, if you know that there's perhaps somebody who's a great fit for your organization but isn't in the right seat, how do you help make that happen? [00:10:29] Brent Lavin: Yeah. So this is back to the seminal Jim Collins book. You know, get the right people on the, on the bus and then get them in the right seat, correct? And so I always tried to select the person first and then find the opportunity. And there are times where you need to pivot people. So let me tell a, a quick anecdote about, you know, a situation where we had somebody on my team, and this person had progressed through different product management roles, but this person also had a project management background and was really passionate about project management and brought those skill sets to product management. But they are different, and that... Her passion was in project management, and so I knew of some upcoming and different opportunities in the organization that would be very project management focused and that, that position was not even on the org chart at the time. But as I had discussions and, and understood that that was becoming a reality, then I turned and, and offered that to the, to the person and ultimately they, they took that new opportunity. And so, it's really understanding really their long-term goals as well as, you know, their strengths, their natural strengths. Not just where they're operating, but what their natural strengths are, and then sometimes even creating an opportunity for them. [00:11:51] Lindsey Dinneen: Mm-hmm. Yeah. Yeah, and so, okay, so, so you've had kind of, a really cool opportunity to get a really good look into some of these startup companies who, you know, their founders might not be in a place where they're able to necessarily hire a whole bunch of people right away. How can you come in and support them when they're, say, like really young, maybe pre-seed, trying to figure out what the next right step is and, and able to sort of help lead them also in that transition of, you know, perhaps single founder to also a leader of a company? [00:12:32] Brent Lavin: Yeah. That's a great question, and I'm early in that journey, right? And so, maybe not some specific examples around that, but certainly again, you know, leadership is influence. And you know, I try to understand as a leader of people in a, an organization what everybody's goals are, personal and professional goals are, and then match, you know, again, what I can do to, to their, to their interests. And so when you talk about, you know, early stage CEOs, sometimes it's just a matter of listening as an unbiased outside observer who has no money in the company. And so, it can just be providing perspective from years of experience and asking insightful questions, you know, even before there's a relationship, a business relationship, between, you know, my company and theirs. And the goal is to help everybody be successful. Like, I'm a passionate medtech leader that wants, you know, th- these innovations to reach market. And so, people have lifted me up along the way, and if, if I can do that just in, in conversations and mentorship, certainly willing to do that and have done that. But as, you know, a CEO transitions then into seed and Series A, just providing, you know, again, leadership perspective from, you know, my corporate experience can be helpful. Because ultimately people are not gonna do things exactly the same way that you've done them as an individual contributor, and you have to become comfortable with allowing people, giving people the, the guardrails, and then allowing them to operate in their own style to achieve the results that you've laid out for them. [00:14:20] Lindsey Dinneen: Hmm. So yeah, and th-that's been something that's been talked about quite a bit is that art of delegating, and how do you give your people the right guardrails without making it so narrow that it feels like you're kind of micromanaging, but you ha- you have to maintain culture and brand, you know, like tone in the way that you speak. So, what are some strategies or tips that you might have for, for a leader who is in the position, needs to delegate? This is maybe a first time. It's a little bit hard to let go of the baby, as it were. So, so how do you help them navigate that? [00:14:55] Brent Lavin: Ye- yeah, I, I would go back to my own experience where, you know, I probably didn't do this the best the very first time that I had people on my team and was delegating. And I would say that most high achievers struggle with delegation for the first time because people are going to do things in a different way than you did. And I tried to teach my way, but as I grew and expanded and got, you know, mentorship and, and learned through that process, I started to go f- you know, higher o- on the ladder to, you know, values and culture and expectations, to your, to your point before. So, as a leader you have to be consistent and just unending in your communication of expectations, values, and standards, and then hold people to those. And so I, I say this often. I live in South Chandler, Arizona, and Scottsdale is maybe 40 minutes away. You know, a new leader would say you know, "You gotta go up the 101, you need to take Exit this and that to get to the coffee shop." Where as I grew more comfortable and confident, I would say, "We're gonna meet at this coffee shop in Chandler." And if they wanted to take surface streets and hit all the stoplights, so be it. And so you gotta become comfortable with that. But at the same time, our standard is "We're gonna meet at this coffee shop at 11 o'clock sharp, and I expect you to be there." [00:16:26] Lindsey Dinneen: That's a great analogy. I love the way you put that. Thanks for sharing it. Yeah, that's-- and that's a really interesting way of thinking about it, is there's, there's many avenues to getting something done correctly and to meet those expectations that you set forth, but there can also be room for creativity on how that's done, how that's accomplished. [00:16:46] Brent Lavin: Yeah. You know, one of the team values that, that I had with my most recent team was around this idea of, of play to win. And you know, over time, I actually adjusted that with some feedback and some further, you know, kinda study on leadership toward striving for excellence. And so I think the play to win was a little bit narrow in that you can't always control everything around you. And winning is an outcome that may be dependent on some other factors that, that you can't influence. And so that was a little bit narrow and, and too outcome-focused. But strive- striving for excellence was something that we could talk about daily, and you may not win, but as long as you strive for excellence in whatever we're asking you to do, like that's the standard. And so, that became a lot more robust, I would say, in the conversations that we had around setting and ensuring expectations. [00:17:45] Lindsey Dinneen: Yes, I love that. Excellence over perfection, especially for those of us who are what I would fondly refer to as a recovering perfectionist. So. [00:17:53] Brent Lavin: Mm-hmm [00:17:54] Lindsey Dinneen: I love that. [00:17:56] Brent Lavin: Yeah, it's a present tense recovering, right? Because we're never fully recovered. But... [00:18:01] Lindsey Dinneen: That's right. That's right. Absolutely. No, I love that. So just out of pure curiosity, when you were, say, I don't know, seven, eight years old, could you have possibly imagined becoming an engineer and/or doing what you do now, which is so much even more robust? [00:18:18] Brent Lavin: Oh my gosh, Lindsey, I love this question, because I couldn't, you know? I didn't. I grew up in small town USA and you know, I, I was really focused on it, you know, being the best at any single sport I could play. I, I was just a ball kid and, and but I loved entrepreneurship. And it's funny you say this because I think in high school, you know, they have those like, "What are you gonna do when you grow up?" I wanted to own a sports bar. And yeah, so like I wanted to help serve good food and, and just have a lot of TVs around and and be an entertainment spot. But I just kind of had that entrepreneurial, you know, itch. And so I, I pretty well knew I was gonna be an engineer just because I was good at technical things, and I loved it. Like, it wasn't work to me. But I didn't even understand what medtech was. And I was 22 years old in my first engineering job. I was six months into the job, and I ended up in the ER on the weekend, and excruciating abdominal pain. And they ran a CT scan, and they found the problem, they relieved the symptoms, they sent me home, and they said, "You need to see the surgeon on Monday morning." Not really understanding what was going on, but I distinctly remember being in that surgeon's office the next week and seeing the axial image of the CT scan on the light box, like the physical light box back then. And I was fascinated. I was fascinated that they chopped my body like a loaf of bread, and within about 30 seconds they could identify the issue. And you know, the surgeon said, "Y- you have this recurrent diaphragmatic hernia, and you're gonna be in surgery in two days." And so I was not scared. I was more fascinated than anything, and that is what crystallized, you know, my need to get into, to medtech. I didn't even know it existed, but I said, "I wanna go do that." And if you fast-forward about five years, there I was working for GE Healthcare, you know, the maker of those CT scanners. And so, I think medtech is really hard. It is not the most glamorous industry. So we all need that why, and for me, again, that Monday morning in the surgeon's office is my why. [00:20:31] Lindsey Dinneen: Hmm. I love that. Yeah, and I love that that's your why, and sort of a follow-up question to that then is, are there any moments that stand out to you along your journey being in medtech that particularly reinforced to you, since making that decision, say, that you are in the right place at the right time? [00:20:52] Brent Lavin: Yeah, and, and I don't mind talking about this. I'll tell this other story. About 12 or 13 years ago, I ended up learning that I had an autoimmune condition, and if you fast-forward, I, I was on some pharmaceuticals, and I've recovered, and I'm all back to normal, but I still live with that. But you go to today, and there are neuromodulation solutions that are addressing autoimmune conditions. And so we're now giving patients a choice between a device-based intervention and a pharmaceutical intervention or a pharmaceutical treatment. And I did not love those pharmaceuticals. They, they had certain side effects and I didn't wanna be on them the rest of my life. Now, I've weaned off of most of them, but patients today are getting an option for a device-based intervention, and so that's what medtech is about. And so when I hear stories of like th- like this, I'm like, "I'm exactly in the right place." And so, there's so much opportunity for us to innovate and impact pa- impact patient lives whether that's ourselves, you know, our family members, or people we may never meet. [00:22:03] Lindsey Dinneen: Yeah. Yeah, thank you for sharing that story. That's-- it's incredible to see. I think one of the best parts about being in the industry is getting to feel hope on a daily basis, yeah? 'Cause there's always something new coming out. These, like you said, medtech is really hard. There are a lot of really tough days, sometimes very not glamorous, and you just... if you have that why, that helps pull you through those days. But I really love what you touched on there of how those innovations that are coming through, that is reason for hope and just optimism again, especially in a, in a world that needs that really badly. [00:22:45] Brent Lavin: Yeah, I think it's easy to be cynical about healthcare. But I guess I choose hope. And yes, we have some structural things that we need to work through. Yes, we have a reimbursement climate or regulatory structure. But to me, that's just a great puzzle, and the, the innovations that do have an impact, not only on healthcare patients, but also economics, are the ones that are gonna win. And so I don't mind that it's a high bar, you know? And so, that just means that we need to all be a little bit better, 1% better, and continue to make a difference. [00:23:20] Lindsey Dinneen: Yeah. No, that's, that's so great. I really love that. Okay, so pivoting the conversation a little bit just for fun. Imagine that you were to be offered a million dollars to teach a master class on anything you want. It can be within your industry, but it doesn't have to be. What would you choose to teach? [00:23:41] Brent Lavin: Yeah. I love that you asked this question, and I could go a lot of different directions. I, I think I'm gonna say, you know, I would love to teach the process of structured customer insights. And so I'm thinking back to the whiteboard of an early stage and then throughout the con- the, the journey of a company. But I think there's a big gap between asking questions to learn and asking the best questions that can ultimately influence your business decision. And so it's not only what you're asking, it's how you're asking it, why you're asking it, and then doing the proper follow-up during the conversation in order to learn the true insight. And so I love baking and I love barbecue, maybe back to my, you know, sports bar dreams. But I think there's a big difference between following the recipe of a baking, you know, process, and doing barbecue, which is very process-oriented and no two things are the same. And so I think we need to approach customer insights a little bit more like barbecue, where you definitely have a goal and a process, but you're willing to adjust and make the changes as you learn in order to affect, you know, the business decisions. [00:25:06] Lindsey Dinneen: Hmm. Yeah. Okay. I really like that. I also like the illustration of the barbecue analogy. That's, that's fun. So okay, so I do have to ask a follow-up question then. So how did this skill set come about for you? Is this something that you, you learned, say, during observations? Or how did you develop this, this masterclass, shall we say? [00:25:28] Brent Lavin: Yeah. I, I think it's, some of it's through my own kind of learning in having conducted just hundreds of physician interviews. And I think, again, early in my career, I used to go through a questionnaire step by step and, and I'd get to the end and I'd have a report, but I may not have the insight. And I think as, again, as I became more comfortable with that process, I would, I would take U-turns or I would take the fork in the road, depending on where the physician was going, and continue to learn maybe not something that was on my roadmap, but something I still needed to learn. And then as I became in- came into leadership, I, I think I just saw it again with early product managers that wanted to follow a recipe and wanted to check a box toward customer insights rather than, again, truly getting in the customer's shoes. I think one of the most fun things of my job in upstream and innovation marketing is when I can interview enough physicians about a particular narrow procedure or product concept, if I can interview enough of them, s- typically between 20 and 30, depending on how complex, and I can start to think like them. And that's the ultimate of a product manager, is to think like the physician. Again, it all depends on how complex the procedure is and whatnot, and we should always be striving to learn. But when you can achieve this secondary kinda personality that mirrors what you've heard from all of these conversations, there's nothing better. [00:27:10] Lindsey Dinneen: Really cool. Okay, excellent. Thank you All right. And then how do you wish to be remembered after you leave this world? [00:27:19] Brent Lavin: Wow. I haven't thought about this in a while. I think, how do I wanna be remembered? Obviously, you know, for my family by, like, leaving, you know, a good family legacy, and also just, I showed up. I just put my shoulder down, did the best I could, certainly wasn't perfect. But I tried to just do the best with what God gave me, and it happens to be in the medtech world right now. And I think I'm uniquely gifted for where I'm at. But I still wanna make more impact over, you know, the next couple of decades. [00:27:55] Lindsey Dinneen: Mm, mm-hmm. Yeah, absolutely. Okay, and then final question. What is one thing that makes you smile every time you see or think about it? [00:28:06] Brent Lavin: Yeah, I, I guess I gotta just go back to my family right now. I got four teenagers, you know, and we're just in an awesome period of life, and I was traveling last week, and just being able to come home, you know, see my wife, see the kids, can't help but smile. So, you know, my two boys are twins, are graduating high school, and those days are, are kinda short, so I'm just trying to soak up every minute of that right now. [00:28:30] Lindsey Dinneen: That's wonderful. I love that. Well, this has been a really great conversation, Brent. Thank you so much for joining me today. We are so honored to be making a donation on your behalf as a thank you for your time today to Save the Children, which works to end the cycle of poverty by ensuring communities have the resources to provide children with a healthy, educational, and safe environment. So thank you so much for choosing that charity to support, and also thank you for continuing to work to change lives for a better world. I'm grateful for you and for your impact on the industry. [00:29:07] Brent Lavin: Well, thanks for this conversation. I've really enjoyed it, and I, I can't wait to continue to stay in touch. [00:29:11] Lindsey Dinneen: Absolutely. Thank you so much. [00:29:14] Dan Purvis: The Leading Difference is brought to you by Velentium Medical. Velentium Medical is a full service CDMO, serving medtech clients worldwide to securely design, manufacture, and test class two and class three medical devices. Velentium Medical's four units include research and development-- pairing electronic and mechanical design, embedded firmware, mobile app development, and cloud systems with the human factor studies and systems engineering necessary to streamline medical device regulatory approval; contract manufacturing-- building medical products at the prototype, clinical, and commercial levels in the US, as well as in low cost regions in 1345 certified and FDA registered Class VII clean rooms; cybersecurity-- generating the 12 cybersecurity design artifacts required for FDA submission; and automated test systems, assuring that every device produced is exactly the same as the device that was approved. Visit VelentiumMedical.com to explore how we can work together to change lives for a better world.

Send us Fan MailWhat if a device small enough to fit in your pocket could detect a potentially fatal heart rhythm before symptoms even appear? My guest today helped make that possible. Dr. David Albert, MD - Founder of AliveCor, pioneered smartphone ECG technology and transformed how millions of people monitor their hearts.Dr. David Albert, MD is a physician, inventor, and serial entrepreneur whose career has helped define the modern era of digital cardiology and personal health technology. A graduate of Harvard College and Duke University School of Medicine, Dr. Albert has spent more than four decades translating breakthrough ideas into life-saving products. He founded Corazonix in the 1980s, Data Critical in the 1990s - which later became part of GE Healthcare - and ultimately served as Chief Scientist and Chief Clinical Scientist for GE Cardiology before returning to entrepreneurship.In 2010, Dr. Albert founded AliveCor ( https://alivecor.com/ ), pioneering the smartphone-based ECG and helping launch one of the earliest and most clinically validated digital health platforms. AliveCor's KardiaMobile technology transformed cardiac monitoring by placing medical-grade electrocardiograms in the hands of millions of consumers and patients worldwide. Beyond AliveCor, Dr. Albert founded InnovAlarm and Lifetone Technology, developing innovations that improve home safety and emergency alerting. An inventor with more than 80 U.S. patents and over 100 scientific publications, Dr. Albert has devoted his career to democratizing healthcare technology and empowering people to better understand - and protect - their own health.#DavidAlbert #AliveCor #KardiaMobile #DigitalHealth #Cardiology #HeartHealth #ECG #AtrialFibrillation #WearableTech #HealthcareInnovation #MedTech #RemoteMonitoring #AIinHealthcare #PrecisionMedicine #PreventiveMedicine #Entrepreneurship #HealthcareTechnology #GEHealthcare #MedicalDevices #FutureOfMedicine #DigitalBiomarkers #HealthTech #Inventor #StartupFounder #Cardiologist #PatientEmpowerment #HeartDisease #MedicalInnovation #ProgressPotentialPossibilitiesSupport the show

"I write for myself, but I edit for the reader." — Liz Lazarus --- ABOUT THIS EPISODE Liz Lazarus is an engineer by education, a GE Healthcare executive by experience, and an author by calling. Her fourth novel, Dawn Before Darkness, is a psychological thriller about a vet tech named Dawn Smith who escapes a toxic relationship only to find herself stalked, harassed, and dragged into a guardianship battle for her aging mother. It's a story ripped from Liz's own life — she spent ten years and thousands of dollars fighting a stranger for legal guardianship of her mom in South Carolina. To build her supervillain, Liz interviewed ten women who survived stalkers and combined their experiences into one relentless antagonist. Mike and Liz talk about writing as therapy, journaling your way into a debut novel, the puzzle of twist endings, self-publishing as self-determination, and why you should sit down with your family and have the uncomfortable estate planning conversation before it's too late. --- KEY TAKEAWAYS 1. Writing began as therapy, not ambition. Liz's first novel, Free of Malice, started as a journal she kept after a man broke into her house in college at Georgia Tech. She didn't know she had PTSD — she just knew journaling was helping her process what happened. That journal eventually became a legal thriller about self-defense. 2. The four things she needs before writing. Liz won't start a novel until she knows the protagonist, the antagonist, the twist ending, and the opening hook. Once those are locked, she outlines, interviews experts, and writes when she has content — no rigid daily schedule. 3. Every book educates and entertains. All four novels carry social causes — self-defense law, stalking, guardianship abuse — but entertainment comes first. The education is baked into the story, never lectured. 4. A ten-year guardianship nightmare inspired the book. Liz fought a family member, then a professional guardian, for control of her mother's care. The judge recused himself; they moved counties; the costs were staggering. Dawn's story in the novel is actually a softened version of what Liz lived through. 5. Ten stalker survivors built one supervillain. Liz put the word out on Facebook asking women with stalker experiences to talk. Several came forward, and she combined their stories into a single antagonist so devastating that reviewers say they've never hated a character more. 6. Characters are real people — and sometimes they surprise you. Liz describes writing in a groove as watching characters on a screen and taking notes. Twice a character did something she didn't plan — including getting fired — and she kept it because human behavior trumps outlines. 7. Self-publishing is owning your destiny. Liz created her own publishing company, learned ISBNs, layout, Mobi, EPUB, and PR from scratch. She values the control — no risk of being dropped by a publisher, no lost say over covers or release dates. 8. A twist must be earned. Inspired by The Usual Suspects, Liz insists every twist must make the reader say "I should have caught that." No tropes, no lost phones — it has to follow from human behavior and planted clues. --- GET THE BOOK Dawn Before Darkness by Liz Lazarus Amazon: https://www.amazon.com/Dawn-Before-Darkness-Liz-Lazarus/dp/099093747X?tag=rettocasgra-20 Barnes & Noble: https://www.barnesandnoble.com/w/dawn-before-darkness-liz-lazarus/1146561497 Bookshop.org: https://bookshop.org/a/54587/9780990937470 Book Website: http://www.dawnbeforedarkness.com/ Also by Liz Lazarus: Free of Malice, Plea for Justice, Shades of Silence --- CONNECT WITH LIZ Website: https://lizlazarus.com Linktree: https://linktr.ee/lizlazarus --- CONNECT WITH YOUR HOST Mike Carlon | Uncorking a Story Website: https://uncorkingastory.com YouTube: @uncorkingastory — https://www.youtube.com/@uncorkingastory Instagram: @uncorkingastory — https://www.instagram.com/uncorkingastory/ Facebook: Uncorking a Story — https://www.facebook.com/uncorkingastory TikTok: @uncorkingastory — https://www.tiktok.com/@uncorkingastory Twitter/X: @uncorkingastory — https://twitter.com/uncorkingastory LinkedIn: Uncorking a Story — https://www.linkedin.com/company/uncorking-a-story/ SUBSCRIBE & LEAVE A REVIEW — It helps more readers and writers find the show! Apple Podcasts: https://podcasts.apple.com/us/podcast/uncorking-a-story/id563636205 Spotify: https://open.spotify.com/show/5HZiAEtFlhAzk60Z4eAkhY RSS Feed: https://feeds.megaphone.fm/uncorkingastory --- Uncorking a Story is produced by Mike Carlon. New episodes drop every Tuesday. --- HASHTAGS #UncorkingAStory #DawnBeforeDarkness #LizLazarus #PsychologicalThriller #ThrillerBooks #WritingCommunity #AuthorInterview #BookPodcast #Stalking #GuardianshipAbuse #ElderCare #SelfPublishing #WomenWriters #TwistEnding #WritersOfInstagram #BookRecommendations #AuthorsOfInstagram #Podcast #SuspenseNovel #TrueCrimeInspired Learn more about your ad choices. Visit megaphone.fm/adchoices

Inspire | Influence | Impact As Engineers Australia celebrates International Women in Engineering Day under the theme Engineering Intelligence, our latest 20 Years of Women on Boards podcast with Dr Bronwyn Evans AM provides a powerful reminder that engineering is about far more than technology. One of Australia's most respected engineers, Bronwyn was the first female CEO of both Engineers Australia and Standards Australia, has held senior executive roles at Cochlear and GE Healthcare, and now serves as a non-executive director across a range of sectors. She is also a long-standing Women on Boards member. In conversation with Claire Braund, Bronwyn reflects on a career shaped by curiosity, pragmatism and a willingness to seize opportunities. Growing up in Wollongong during a period of significant industrial growth, she developed an appreciation for practical problem-solving, multicultural collaboration and the belief that education could create opportunities regardless of background. A recurring theme throughout the discussion is the value engineers bring to leadership and governance. Bronwyn believes engineers are uniquely equipped for board roles because of their systems thinking, ability to understand complex problems and disciplined approach to decision-making. While engineers are often associated with technical expertise, she notes that many progress into executive leadership, strategy, operations and transformation roles, making them valuable contributors in the boardroom. The conversation also explores the evolution of technology, from punch-card programming and early automation systems through to today's AI-enabled world. Having completed a PhD in real-time robotic control systems, Bronwyn reflects on how rapidly technology has evolved and why engineers must continue to adapt and embrace new tools while maintaining a focus on solving meaningful problems. As discussions around artificial intelligence continue to dominate board and executive agendas, Bronwyn offers a thoughtful perspective on both the opportunities and challenges ahead. She highlights the importance of maintaining trust, integrity and standards while recognising that AI will continue to reshape how organisations operate and innovate. Bronwyn also reflects on the important role Women on Boards has played throughout her governance journey. Having joined WOB in 2007 while working at Cochlear, she describes the organisation as an egalitarian community where women can test ideas, learn from one another and access opportunities. She recalls the influence of early WOB conferences and the insights gained from global discussions about increasing women's representation on boards. Looking to the future, Bronwyn sees the next challenge as increasing diversity in all its forms, including bringing younger women, culturally diverse women and more engineers into boardrooms. Her message is clear: diverse perspectives lead to better thinking, better governance and better outcomes. Asked to summarise her journey over the past two decades, Bronwyn chose three words: opportunistic, enjoyable and learning. They are fitting reflections from a leader who has spent her career embracing new challenges, championing engineering and helping create pathways for future generations of women leaders. Learn more about Women on Boards

Rashmi Airan had it all—an Ivy League education, a successful law career, and a bright future.Then everything changed.After becoming entangled in a mortgage fraud scheme during the housing boom, Rashmi faced federal prosecution, prison, and the public collapse of the life she had spent decades building.But prison did not become her ending.Today, Rashmi is a globally recognized keynote speaker who has spoken for companies including Coca-Cola, Deloitte, Merck, Comcast, Caesars Entertainment, Hershey's, and GE Healthcare. Through her Rise Through It® framework and her new book ALL RISE, she helps leaders transform adversity into courage, accountability, and growth.In this unforgettable conversation with Brent Cassity, Rashmi shares her journey from ambition and success to failure, prison, and ultimately purpose.This is a story of owning your mistakes, rebuilding trust, and discovering that your worst moment does not have to define your future.Show sponsors: Navigating the challenges of white-collar crime? The White-Collar Support Group at Prisonist.org offers guidance, resources, and a community for those affected at prisonist.org. Protect your online reputation with Discoverability! Use code NIGHTMARE SUCCESS for an exclusive discount Visit Discoverability.co. Auto Plaza Direct "Your personal car concierge!" Let them handle every detail to find your perfect car autoplazadirect.com. Author Saffron Gustafson www.mynameissaffron.com, "My Name is Saffron." Author Nevin Shetty, "Second Chance Economics: How Hiring The Formerly Incarcerated Can Unlock $1 Trillion in GDP." www.secondchanceeconomics.com

On this special industry sponsored episode, host Praveen Ranganath, MD is joined by Dr. Brandie Williams (cardiology) and Dr. Nanette Evans (radiology) who share how they brought advanced cardiac CT imaging to a small-town community in Stephenville, TX. What began as a vision to improve access and reduce delays in diagnosis evolved into a powerful partnership that transformed patient care pathways.The conversation explores the challenges of launching new technology in a rural setting, the importance of cross-specialty collaboration, and the real impact on patient outcomes—from faster answers to fewer unnecessary procedures. Through practical insights and personal stories, this episode highlights how innovation, trust, and a shared mission can expand access to high-quality care and reshape how communities think about cardiac health.This episode is sponsored by GE HealthCare. References to a specific product, process, or service by speakers in this podcast episode do not constitute or imply an endorsement by the Society of Cardiovascular Computed Tomography. The views and opinions expressed in do not necessarily reflect those of the Society of Cardiovascular Computed Tomography.

Condensation in an anesthesia circuit looks harmless until it starts skewing flow sensor readings or creating the kind of warm, wet environment where microbes can thrive. We pick up the story after the investigation into moisture and mold concerns in GE operating room ventilators, then move straight into the questions clinicians asked most: which filters matter, how low-flow anesthesia changes the moisture equation, and what “moisture mitigation” actually means at the bedside.We walk through APSF guidance on filtration, including why a high-quality filter between the expiratory limb and the anesthesia machine is a key defense for keeping respiratory pathogens out of the workstation. We also talk about what HME filters do well for airway humidity and reducing moisture entering the machine, where their limits are (especially moisture generated by CO2 absorption), and why sidestream gas sampling lines deserve more attention in infection prevention and anesthesia machine protection.Then we share GE Healthcare's response, including what's universal across modern anesthesia breathing systems, what features support moisture management, and when optional condensers may help depending on clinical usage patterns.If this topic affects your OR workflow, subscribe, share the episode with a colleague, and leave a review so more anesthesia professionals can find these moisture management and patient safety insights.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/310-moisture-matters-in-anesthesia-circuits/© 2026, The Anesthesia Patient Safety Foundation

Was medical physicist an option at your school's career day? If so, lucky you! But if not, you're not alone. It's a pretty niche field, but it has a significant impact on the future of personalized medicine and treating diseases. If you're thinking that this sounds like an intriguing career path, we're joined by physicists working in several different areas of nuclear medicine: quality control, equipment calibration, and research. Ben Auer, PhD, hosts this episode as we learn more about how our guests discovered their career in medical physics, the qualifications needed, and the various opportunities that come with this highly rewarding field. Tune in now!This episode of the Podcast is sponsored by GE HealthCare.Vizamyl Important Safety InformationPRODUCT INDICATIONS AND USEVIZAMYL™(flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for:Evaluation of Alzheimer's disease(AD) and other causes of cognitive declineSelection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.CONTRAINDICATIONSVIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80.ADVERSE REACTIONSThe most commonly reported adverse reactions in clinical trials were flushing(2%), increased blood pressure(2%), headache nausea and dizziness(1%).Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-pi Want more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

One third of all data generated globally comes from the healthcare sector, yet a staggering 97% of it remains unused, trapped in siloed systems. This "big crime" of wasted potential is exactly what Simon Rost and his team at GE Healthcare are determined to solve. As the Global Marketing Officer for Enterprise Imaging, Simon sits at the helm of a business that touches over a billion patients a year. In a world where medical imaging is the bedrock of diagnosis, the challenge isn't just about capturing the image anymore—it's about what we do with the intelligence hidden within it. In this episode, Simon breaks down the transition from "Big Iron" hardware to the invisible power of enterprise medical imaging software. We dive into the rise of Agentic AI—AI that doesn't just analyze but takes action—and how GE Healthcare is moving toward a future of autonomous imaging to free up clinicians for what matters most: the patient. We also explore the critical shift in commercial models from CapEx (capital expenditure) to SaaS (software-as-a-service), the necessity of an open ecosystem over "walled gardens," and why interoperability must be the innovation of the decade. Simon even shares a personal anecdote about how GE's technology bookended the birth of his son, bringing the scale of MedTech down to the most human level. Whether you are a radiologist, a healthtech entrepreneur, or a data enthusiast, this conversation is a masterclass in how a global giant is retooling for the AI-first era of medicine! Timeline: 00:00:00 - Simon's journey in MedTech and enterprise imaging software at GE Healthcare 00:05:50 - The trends of AI in healthcare from Simon's perspective 00:12:04 - Where AI and hardware meet in medical devices 00:14:35 - Positioning GE Healthcare's portfolio along the end-to-end patient journey 00:20:27 - How GE Healthcare builds the value proposition and commercial models of its enterprise imaging software 00:28:15 - GE Healthcare's philosophy regarding partnerships and building ecosystems 00:33:37 - Simon's predictions for the future of medical imaging What we also talked about with Simon: Healthcare Information and Management Systems Society (HIMSS) GE Healthcare's Hello AI Program We mentioned with Simon some of the past episodes of the series: #16 - Making ultrasound portable to transform medical imaging - Ohad Arazi - Clarius #32 - Accelerating radiology with AI - Amine Korchi - Radiologist #36 - Turning healthcare preventive with full-body MRI scans - Andrew Lacy - Prenuvo #47 - Pushing responsible AI in health - Dr. Ricardo Baptista Leite - HealthAI As mentioned by Simon during the episode, you can have a read at Ground Truths by Dr. Eric Topol and his recent book Super Agers, offering exhaustive and evidence-based insights on the science of longevity, and the role medical imaging in it. Simon also recommends checking out The Medical Futurist website by Dr. Bertalan Meskó, a bible for everything around medical technology and the latest innovations in the space. You can get in touch with Simon via LinkedIn, and follow GE Healthcare's activities on their website, LinkedIn, Facebook, Instagram, X, and YouTube. ✉️ If you want to give me feedback on the episode or suggest potential guests, contact me over LinkedIn or via email! ⭐️ And if you liked the episode, please share it, subscribe to the podcast, and leave a 5-star review on streaming platforms!

Black particles in a breathing system are the kind of finding that makes every anesthesia professional stop and look twice. We're sharing what a large health system uncovered after concerns for mold and moisture accumulation surfaced inside certain GE Healthcare anesthesia workstations used in operating rooms, especially during longer cases and in humid conditions. What started with a routine inspection quickly scaled into a broad audit of OR ventilators, a review of internal moisture points, and an urgent push for real-world mitigation.We walk through what the investigation found, what cultures grew, and the question everyone asks first: what is the risk to patients? We discuss why the available evidence suggests the infectious risk is likely minimal when high-quality heat and moisture exchange (HME) filtration and breathing circuit filters are used correctly, and why the team still pulled affected machines from service for sterilization per manufacturer instructions. Patient safety isn't only about infection, though, and we also cover how excess condensate can affect flow sensors and tidal volume accuracy.Then we get concrete about prevention. We break down where moisture comes from inside an anesthesia ventilator, how low-flow anesthesia and rebreathing can increase water production in the circuit, and why simply turning up fresh gas flow isn't the right fix when cost and environmental impact matter. You'll hear the day-to-day moisture mitigation strategies that were implemented, including education, routine moisture and mold checks, overnight handling of circuits and sensors, and why add-on condenser drainage may be necessary for older compatible models.If you want a practical checklist mindset for anesthesia workstation maintenance, OR ventilator safety, and moisture management, this is for you. Subscribe, share with your colleagues, and leave a review so more teams can spot problems early and keep patients safe.For show notes & transcript, visit our episode page at apsf.org: https://www.apsf.org/podcast/309-mold-risk-in-anesthesia-workstations/© 2026, The Anesthesia Patient Safety Foundation

India's medical devices industry is entering a high‑growth phase, with the market set to expand from USD 14 billion today to nearly USD 30 billion by 2030. With India ranking among the top 20 MedTech markets globally, the healthcare ecosystem is taking several steps and initiatives that are steering the country toward sustained growth in the sector. In this episode, we are joined by Raghavendra Rao, Chief Operating Officer – Distribution, Wipro GE Healthcare, who highlights that demand, a supportive public‑policy environment, and the shift from reactive care to early prediction are three key pillars that will drive India's MedTech opportunity. He also reflects on the company's journey of ‘Make in India, for India, and for the World' and how GE HealthCare plans to build on this momentum going forward.

OxygenCare, a leading Irish medical device distributor with over 54 years of experience supporting anaesthesia and critical care, has announced the Irish launch of the GE Carestation 850 Anaesthesia Delivery System at the College of Anaesthesiologists of Ireland (CAI) Annual Congress, held in O'Reilly Hall, UCD. The launch marks a significant milestone in OxygenCare's long-standing partnership with Irish healthcare, reflecting more than five decades of innovation supporting clinicians, from early gas delivery systems to today's connected, data-driven care environments. As the exclusive Irish distributor for GE HealthCare's anaesthesia portfolio, OxygenCare is introducing the GE Carestation 850 as a Digital for Care-ready platform, aligned with the HSE's evolving digital infrastructure, including the One Health Record (National EHR), NIMIS, and future integrated care systems. "The theme of this year's CAI Congress, 'The Evolution of Anaesthesia and Critical Care', perfectly reflects our journey," said Maurice Moran, Managing Director, OxygenCare. "For over 50 years, we have enabled Irish clinicians to deliver safer, more effective care as technology has evolved. The GE Carestation 850 represents the next step: advanced clinical performance combined with seamless digital integration, fully aligned with HSE Digital for Care standards. We are proud to launch it here among the clinicians shaping the future of anaesthesia in Ireland." Designed for Ireland's Digital Healthcare Ecosystem The GE Carestation 850 is built as a fully connected medical device, supporting the transition from paper-based workflows to a data-driven, integrated perioperative environment. Key Digital Features include: Interoperability by Design: Simplifying connections to other medical devices and to hospital networks. Real-time data transmission can be configured to automatically send important physiological, machine and service data to various clients simultaneously. Integrated Care Connectivity: Bi-directional data exchange with Shared Care Record and future Community Care Record. Cybersecurity Framework: Future-ready: Extra computing power to accommodate smart tools and features. AI-Ready Architecture: Supports future decision tools such as predictive alerts and ventilation optimisation. Advanced Clinical Performance The GE Carestation 850 is engineered to support the evolving demands of anaesthesia and critical care: Advanced ventilation modes for both low-flow and high-flow anaesthetic techniques. High-resolution touchscreen interface for intuitive operation and rapid clinical decision-making. Efficient vapouriser and gas management systems. Native integration with anaesthesia information systems and hospital PAS. End-tidal control (Et Control) Automatically adjusts fresh gas flows to maintain EtO2 and EtAA targets. The new GE Carestation 850 is a platform for today and for the future – engineered with digital architecture that supports ongoing software innovations while delivering advanced clinical performance combined with seamless digital integration.The system will be displayed at the CAI Congress, continuing OxygenCare's long-standing commitment to engage directly with Ireland's anaesthesia community. See more stories here. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience. You can also find and follow us on Twitter, LinkedIn, Facebook, Instagram, TikTok and Snapchat.

In der heutigen Folge sprechen die Finanzjournalisten Lea Oetjen und Holger Zschäpitz über resiliente Börsen, das „graue Nashorn“ in China und ein dickes Versprechen bei Qualcomm. Außerdem geht es um Alphabet, Amazon, Microsoft, Meta, Robinhood, Bloom Energy, Plug Power, Fuelcell Energy, Siemens Healthineers, GE HealthCare, Adidas, Scout24, Mercedes-Benz, Deutsche Bank, DWS, Inovance, Siasun Robot & Automation, Estun Automation, iShares Automation & Robotics ETF (WKN: A2ANH0) und L&G ROBO Global Robotics and Automation ETF (WKN: A12DB1). Wir freuen uns an Feedback über aaa@welt.de. Noch mehr "Alles auf Aktien" findet Ihr bei WELTplus und Apple Podcasts – inklusive aller Artikel der Hosts. Hier bei WELT: https://www.welt.de/podcasts/alles-auf-aktien/plus247399208/Boersen-Podcast-AAA-Bonus-Folgen-Jede-Woche-noch-mehr-Antworten-auf-Eure-Boersen-Fragen.html. Hier könnt ihr den AAA-Newsletter abonnieren: https://www.welt.de/newsletter/article232797673/Alles-auf-Aktien-Der-taegliche-Boersen-Newsletter-fuer-WELTplus-Abonnenten.html Und - ganz neu: AAA gibt es jetzt auch auf Instagram: https://www.instagram.com/alles_auf_aktien/ Disclaimer: Die im Podcast besprochenen Aktien und Fonds stellen keine spezifischen Kauf- oder Anlage-Empfehlungen dar. Die Moderatoren und der Verlag haften nicht für etwaige Verluste, die aufgrund der Umsetzung der Gedanken oder Ideen entstehen. Hörtipps: Für alle, die noch mehr wissen wollen: Holger Zschäpitz können Sie jede Woche im Finanz- und Wirtschaftspodcast "Deffner&Zschäpitz" hören. +++ Werbung +++ Du möchtest mehr über unsere Werbepartner erfahren? Hier findest du alle Infos & Rabatte! https://linktr.ee/alles_auf_aktien Impressum: https://www.welt.de/services/article7893735/Impressum.html Datenschutz: https://www.welt.de/services/article157550705/Datenschutzerklaerung-WELT-DIGITAL.html

Why do so many great MedTech products stall after launch — even when the data is there? In this episode of Med Tech Gurus, we're joined by Amy Brouhle, Vice President of Strategic Business Development at S2N Health. A former emergency department nurse turned commercialization leader, Amy brings more than 20 years of experience spanning clinical care, GPO strategy, national accounts, and MedTech growth. Her career includes senior roles at Vizient, Hillrom, and GE Healthcare, giving her a rare, end-to-end view of how innovation actually gets adopted — or stuck. At S2N Health, Amy helps MedTech companies cut through the noise of fragmented data and turn insight into action. We explore why most organizations don't have a data problem — they have an insight problem — and how aligning sales, marketing, and strategy around the right signals can unlock utilization, accelerate adoption, and improve investor confidence. From GPO dynamics and channel strategy to AI-powered targeting, territory planning, and go-to-market execution, Amy shares practical lessons every founder and commercial leader needs to hear. If you're trying to translate innovation into revenue and scale, this is a conversation you won't want to miss.

Episode 175: Veronica Lynn Clark, M.S. and her book, To Be Aligned: Getting Clear on Your Higher PurposeABOUT VERONICAVeronica Lynn Clark is a trailblazer in personal transformation, intimacy empowerment, and somatic healing. With nearly two decades of experience, she has guided countless individuals in reclaiming their power, healing from trauma, and living with greater authenticity and purpose. Her work blends deep compassion with profound expertise, creating transformative spaces where individuals feel safe to explore vulnerability and step into their fullest selves.A certified Somatic Experiencing Practitioner, Intimacy Coach, and Transformational Speaker, Veronica is known for demystifying complex emotional and relational dynamics while providing practical tools for healing and self-discovery. She is also a yoga and meditation teacher and the best-selling author of To Be Aligned: Getting Clear on Your Higher Purpose and Better Sex, Less Drama (series)Veronica has led workshops and retreats at venues such as Civana Wellness Resort and Spa, collaborated with organizations including Google, GE Healthcare, and Thrivos, and has been featured on the Today Show for her expertise in personal growth and wellness.CONVERSATION HIGHLIGHTS• Veronica's inspiring background: from banking and real estate to healing and self-love• How childhood trauma and a mental health crisis shaped her path to healing• The role of mindfulness, yoga, and sacred sexuality in her transformation• Her approach to self-concept, values, and living aligned with your highest purpose• The creation and evolution of her book, To Be Aligned, as a tool for self-discovery• Insights into leadership: honesty, accountability, humility, and leading with love• The power of storytelling and owning your unique life journey• Upcoming retreats, trainings, and the launch of her audiobookThe MAIN QUESTION for you that comes out of my conversation with Veronica is, What is the highest vision you have for yourself, and what's stopping you from attaining it?FIND VERONICA• LinkedIn: https://www.linkedin.com/in/veronicalclark/• Website: www.veronicalynnclark.com• The Better Sex, Less Drama™ Series: https://www.veronicalynnclark.com/better-sex-less-drama-book-series• Instagram: https://www.instagram.com/veronicalclark/LinkedIn - Full Podcast Article: CHAPTERS00:00 - The Book Leads Podcast - Veronica Lynn Clark00:50- Introduction & Bio01:59 - Who are you today? Can you provide more information about your work?03:37 - How did your path into your career look like, and what did it look like up until now?06:49 - Veronica & Volunteer Work30:24 - How does the work you're doing today reconcile to who you were as a child?33:03 - What is your superpower?35:17 - What does leadership mean to you?40:46 - Can you introduce us to the book we're discussing?48:06 - Can you provide a general overview of the book?59:25 - What's changed in you in the process of writing this book?01:02:11 - What book has inspired you?01:05:11 - What are you up to these days? (A way for guests to share and market their projects and work.)This series has become my Masterclass In Humanity. I'd love for you to join me and see what you take away from these conversations.Learn more about The Book Leads and listen to past episodes:· Watch on YouTube· Listen on Spotify· Listen on Apple Podcasts· Read About The Book Leads – Blog PostFor more great content, check out the catalog for my newsletter Last Week's Leadership Lessons, if you haven't already!

Host Justin Barnes records live at HIMSS26 in Las Vegas. Stay tuned for the next few weeks to hear all his guests.This week, Simon Philip Rost, Chief Marketing Officer, GE HealthCare and Charles Barkey, Vice President Information Technology – Northern Panhandle WVU Medicine Hospitals. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode, Brent Lavin shares how two decades in product and portfolio management at GE Healthcare, C.R. Bard, and BD shaped his mission to help Series A and B medtech startups build commercial logic into every stage of innovation. Brent breaks down what surprised him most moving from strategics to early-stage teams and why large companies often operate like startups when resources must be earned through influence, not authority. The conversation dives into how his engineering training powers a structured, “marketing-as-a-science” approach to product management, the most-missed elements of customer discovery, and a concrete example of winning by simplifying a “Cadillac” product into a segmented solution. Brent also unpacks what strategics look for in acquisitions plus lessons from LSI, leadership, and the discipline of endurance running.Brent Lavin LinkedInIronwood Medtech Partners LinkedInDuane Mancini LinkedInProject Medtech WebsiteProject Medtech LinkedInThank you to our sponsors: Ward Law and JumpStart Inc.

This year, 125.6 million people tuned in to watch the Seahawks face the Patriots in the Super Bowl. While the game was the main draw, it's perhaps the one time of year that commercials generate equal excitement. 2026 was no exception, but before the first quarter ended, it was clear which industry dominated the 2026 ad buys: artificial intelligence. AI has become ubiquitous in daily life, and there's almost no industry that hasn't been impacted by its adoption, including nuclear medicine. While some of its applications are clear, questions remain about how AI will be used in clinical settings, patient interactions, image interpretation, and more. On this episode of the SNMMI Podcast, Lance Burrell moderates a discussion with Dmitry Beyer, MPA, CNMT, and Samantha Heasty on AI and its capabilities, potential, and shortcomings. Tune in now!This episode of the SNMMI Podcast is sponsored by GE Healthcare.Important Safety Information – VIZAMYLPRODUCT INDICATIONS AND USEVIZAMYL™ (flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for:· Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline· Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.CONTRAINDICATIONSVIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80.ADVERSE REACTIONSThe most commonly reported adverse reactions in clinical trials were flushing (2 %), increased blood pressure (2 %), headache (1 %), nausea and dizziness (1 %). Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-piWant more SNMMI content? Follow us on:YouTube | Instagram | LinkedIn | Twitter/X

Stacey Tank is a 20+ year Fortune 500 veteran and currently Chief Executive Officer for Bespoke Beauty Brands (BBB), owner of high-growth cosmetics brands Jason Wu Beauty and KimChiChic Beauty, which can be found in places like Target, CVS, Walmart, JCPenney, Amazon, the TikTok Shop and beyond. BBB was founded in 2019 by serial entrepreneur Toni Ko who sold her first cosmetics company, NYX, to L'Oreal. Prior to BBB, Tank was based in Amsterdam in the role of Chief Transformation Officer for HEINEKEN (AMS: HEIA) with €29 billion in annual revenues and over 100,000 employees. As a direct report to the CEO and member of the executive committee, Tank co-created and later shepherded the company's growth strategy, "EverGreen," to ensure the organization adapted amidst a rapidly changing environment including a focus on top quartile growth and multi-billion euro cost out. In addition, Tank was responsible for the company's sustainability strategy, Brew a Better World 2030, including the design of its net zero carbon ambition. Tank formerly led the multi-billion dollar Home Depot Installation Services and Home Depot Measurement Services businesses for The Home Depot (NYSE: HD), the world's largest home improvement retailer with $132 billion in sales and 500,000 employees. During her tenure, Tank led the exit of four unprofitable lines of business and returned the remaining businesses to double-digit growth while strengthening the organization's culture, talent bench and innovation pipeline. Dedicated to the intersection of business and positive impact on society, Tank has repeatedly authored large-scale movements across enterprises like General Electric, HEINEKEN and The Home Depot including launching a quarter-of-a-billion-dollar commitment to veteran housing and a $50 million shop class program that is infusing 20,000 skilled tradespeople into the US economy. Before joining The Home Depot, Tank was a Senior Vice President for HEINEKEN USA @StaceyTank Stacey.M.Tank@gmail.com (AMS: HEIA), the leading importer of upscale beers in the US. Tank reported to thenCEO Dolf van den Brink and as part of the company's management team, navigated a difficult and successful turnaround period. Previously, from 2002 to 2011, Tank worked at General Electric (NYSE: GE), where she held a variety of global finance, audit, communications and marketing roles across GE Healthcare, NBC Universal, GE Capital, GE Energy, GE Aviation and GE Corporate (including GE's Communications Leadership Development Program and Corporate Audit Staff) in countries including Mexico, Brazil, Germany, the UK, France, Canada and the US. Tank is the founder of Our Happy Place (OurHappy.org), a 501(c)3 non-profit serving children, educators and families navigating childhood mental wellness. She also sits on the board, audit and compliance committees for Blackstone-owned Interior Logic Group, the leading US installer of interior finishes for new home construction. Tank previously sat on the boards of the Heineken Africa Foundation, American Chamber of Commerce in the Netherlands, Woodruff Arts Center (nominating and governance chair), Serenbe Playhouse, Ad Council, Home Depot Foundation (former president), Homer Fund, Bright Pink (executive board), Academy for Systems Change (finance committee), Arthur W. Page Society (digital committee), Westchester Business Council, Beer Institute, Institute for Public Relations and Subrosa (sold in late 2017). She is the former vice chairwoman of the National Association of Beverage Importers and the former chairwoman of the Heineken Good Government Fund. Tank is a 2020 World Economic Forum Young Global Leader (YGL), a 2019 Henry Crown Fellow at the Aspen Institute and a 2014 Academy for Systems Change Fellow. She graduated summa cum laude with a Bachelor of Science from Syracuse University's Newhouse School and Whitman School of Management where she was recognized as a University Scholar, the university's highest academic honor. Tank has been married for nearly 20 years and has three sons, two human and one canine.

Staffing shortages. Growing waitlists. Fixed capacity. Radiology leaders are running out of room to experiment, and AI is moving from “nice to have” to operational necessity.In this interview, Roland Rott, CEO and President of Imaging at GE Healthcare, explains why health systems are rethinking how AI fits into daily radiology operations. The focus is not on future promises, but on how AI is already being used to save time, reduce friction, and turn long-unused data into practical workflow improvements. The discussion spans staffing constraints, trust in AI, and why operational impact is now driving adoption.

In this episode of the Medical Sales Podcast, host Samuel Adeyinka sits down with Marie Robert, a GE Healthcare product sales specialist, to break down what it's really like selling capital medical equipment in one of the most competitive markets in the world. Marie shares how she entered the industry through GE's Commercial Leadership Program, what a day in the life of a New York City medical sales rep looks like, and how selling anesthesia machines requires deep hospital relationships, strategic thinking, and constant collaboration with physicians, procurement teams, and biomedical engineers. She also discusses the realities of working in a large corporate environment, the future of medical sales in an AI driven world, and the mindset, discipline, and resilience needed to succeed in this fast paced and highly competitive industry. Connect with Marie Robert: LinkedIn Connect with Me: LinkedIn Love the show? Subscribe, rate, review, and share! Here's How »

In this episode, host Sandy Vance chats with Hari Bala, the Chief Technology Officer for Health Information Systems at Solventum. Together, they explore how healthcare organizations can build trust and confidence around AI adoption, drawing on insights from Solventum's recent global survey of healthcare professionals. The research highlights a growing demand for AI alongside concerns that innovation could increase pressure on clinicians. Hari shares practical perspectives on how AI can support rather than overshadow providers, improve efficiency without compromising quality, and help organizations introduce new technologies in ways that feel safe and sustainable. Listen to learn how leaders can ensure clinicians feel comfortable incorporating AI into their daily workflows while improving the overall patient experience. In this episode, they talk about: The three key trust factors and why trust is the foundation for AI adoption Why trust is the currency of successful implementation The role of AI in improving patient care and clinician efficiency How speed and quality can improve together rather than compete Key findings from Solventum's healthcare AI adoption survey The cultural and mindset shifts required for successful implementation The impact of AI on the patient experience How leaders can evaluate potential technology partners A Little About Hari: Hari Bala joined Solventum as Chief Technology Officer for Health Information Systems in May 2025. He brings more than 25 years of experience building scalable, distributed systems using generative AI, data science, analytics, and machine learning across healthcare, cloud, and security. Before Solventum, Hari led AI, data, analytics, and cloud transformation initiatives at GE Healthcare and Oracle Cerner. At Oracle, he helped establish the AI Services organization and led development of the Health Data Intelligence and Analytics platform, a near real-time, cloud-based population health solution, while advancing AI and machine learning tools for clinical use. Earlier in his career, Hari spent nearly 19 years at Microsoft in leadership roles across Azure and several core enterprise technologies.

Radiology teams don't need more dashboards. They need clearer signals about capacity, and better image quality. This conversation looks at how small, practical changes, powered by AI, make a real difference.In this video, Lily Belcak, Customer Success Leader at GE Healthcare, explains how analyzing DICOM data directly from imaging devices helps health systems better understand how long exams actually take and where schedules can be adjusted. The result is more accurate appointment planning and improved access without adding staff or equipment.You'll also hear from Laura Hernandez, Chief Marketing Officer for Women's Health and X-ray at GE Healthcare, on how Pristina Recon DL focuses on image clarity and reading efficiency. Clearer images support faster reads for radiologists and reduce the need for repeat scans, especially in breast imaging where precision matters.

So much of what we know about heart health is based on male models. Classic heart attack symptoms describe the experiences of men, drugs were developed largely by men for men—even in research, mouse models were male. But in recent years, our understanding of women's cardiac health has expanded, and critically, we have learned that we cannot simply apply male models to female patients. As one of our guests says, "women are not small men." For American Heart Month, join us for a heart-to-heart with members of the SNMMI Cardiovascular Council as they discuss how nuclear cardiology is providing new insight into women's heart health. Listen here or wherever you stream your podcasts. This episode of the SNMMI Podcast is sponsored by GE Healthcare.Important Safety Information – VIZAMYLPRODUCT INDICATIONS AND USEVIZAMYL™ (flutemetamol F 18 injection) is indicated for positron-emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density in adults with cognitive impairment for:· Evaluation of Alzheimer's disease (AD) and other causes of cognitive decline· Selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing of information of the therapeutic products.CONTRAINDICATIONSVIZAMYL is contraindicated in patients with a history of hypersensitivity reaction to VIZAMYL or polysorbate 80.ADVERSE REACTIONSThe most commonly reported adverse reactions in clinical trials were flushing (2 %), increased blood pressure (2 %), headache (1 %), nausea and dizziness (1 %). Postmarketing experience included anaphylactic reactions. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.Prior to VIZAMYL administration, please read the full Prescribing Information for additional Important Safety Information: https://gehealthcare.com/vizamyl-pi

What separates companies that scale smoothly from those stuck in constant firefighting mode? Hector Sanchez, founder of PCK Partners with 18 years leading supply chain and procurement teams at GE Healthcare and major aerospace manufacturers, reveals it's not the processes—it's the people, and more specifically, how you lead them. In this conversation with Vince Perry, Hector breaks down how he slashed employee turnover from 30% to 8% without throwing money at the problem, just by fundamentally changing the culture. From coaching high school soccer to leading multi-million dollar transformations, Hector explains why the fundamentals of great leadership are identical whether you're on the field or in the boardroom. He shares the exact moment he realized that loud voices in the room aren't always the smartest ones, and how empowering his quietest team member became the key to driving change faster. You'll discover why breaking big visions into small, incremental wins gets buy-in while grand announcements create resistance, and the critical question he asks teams to make them realize changes need to happen—without him having to demand it. Hector pulls back the curtain on the biggest mistake founders make when hiring executives (hint: you can't retain control and expect top talent to succeed), why living your core values matters infinitely more than posting them on a wall, and the surprising truth about working with an $8 million business versus a $60 million operation. Whether you're running a collision shop, a nonprofit, or a Fortune 500 division, Hector proves that a business is a business—it just has fewer zeros. If you're tired of watching talented people walk out the door or struggling to get your team aligned on the vision, this episode delivers the leadership toolkit you've been missing. Thank you for being a vital part of our channel

In this episode of the HR Leaders Podcast, we sit down with David Sperl, Head of HR for Advanced Visualization Solutions at GE HealthCare, to unpack how HR earns real business credibility by shipping outcomes, not PowerPoints, inside a heavily regulated, science driven environment.David explains why AI literacy must move from theory to hands-on practice, how microlearning and shared baseline tools help drive adoption, and why leadership advocacy is essential to scale change across technical, clinical, and commercial teams. He breaks down GE HealthCare's four stages of AI adoption, how communities of practice create demand pull, and why unlearning outdated mental models is now harder than learning new ones.Most importantly, he shares why user experience and friction removal are the real unlocks for AI in HR and business, and why the future of change isn't “change management”, it's change agility.

In this episode, host Sandy Vance sits down with Parminder Bhatia , the Chief AI Officer from GE HealthCare , for a thoughtful, forward-thinking conversation about the rapidly shifting landscape of AI in healthcare. Together, they explore why healthcare is so ready for transformation, the four critical areas where change is most urgent, and how smarter systems can ease some of the industry's most complex workflows. Sandy and Parminder dig into how foundation models and the rise of agentic AI can finally help healthcare move beyond fragmented solutions. In this episode, they talk about:How AI is transforming a healthcare industry that's long overdue for changeThe four key areas where transformation is most neededStreamlining some of the most complex medical processesHow better communication and information can assist clinicians during labor and deliveryUsing foundation models to reduce fragmentation in healthcare AISupporting the multi-step workflows of radiologistsWhy agentic AI represents the future of healthcare innovationA Little About Parry:At GE HealthCare, Parry is focused on integrating AI across smart devices, across the patient journey, and at the hospital operations level. The company is a long-time leader in healthcare AI, topping the FDA's list of AI-enabled devices for four consecutive years with more than 115 authorizations. Parry's team advances AI within medical devices to improve patient outcomes, and he also serves on the company's responsible AI committee to ensure new solutions are reliable, scalable, and ethical. His work has earned recognition from Modern Healthcare's 40 Under 40, the AIM AI 100 Awards, and Constellation Research's AI 150. Before joining GE HealthCare, Parry was Head of Applied Science at Amazon, contributing to machine learning and generative AI products such as Amazon Comprehend Medical. He previously held AI and machine learning roles at Microsoft and Georgia Tech. He holds a B.S. in Computer Science from the Indian Institute of Technology and an M.S. in Computational Science and Engineering from the Georgia Institute of Technology.

In this episode, host Sandy Vance and Hari Balasubramanian, the Chief Technology Officer, Health Information Systems at Solventum, sit down for a deep dive into how AI-driven healthcare technology is reshaping the industry. Together, they explore how Solventum is building innovative products and services that streamline documentation, billing, and coding while improving the patient experience and saving valuable time for healthcare professionals. From what's happening at Solventum right now to the company's move toward fully autonomous coding, this conversation unpacks how healthcare payers and providers can rethink financial performance in the age of artificial intelligence. Hari also shares practical insights for CIOs evaluating these systems and explains how Solventum measures real-world improvements driven by AI. If you're interested in healthcare innovation, revenue cycle transformation, or the future of AI in health information systems, this is an episode you won't want to miss.Check out Solventum's Education Session and Case Study Session that was presented in the AI Zone at HLTH 2025.In this episode, they talk about:What's going on with Solventum right nowHow Solventum is serving healthcare payersSolventum's move toward complete autonomous codingThe common misconceptions about improving financial performance for providersHow CIOs should evaluate their work when engaging with these systemsMeasuring the improvements produced by AI with Solventum's systemsA Little About Hari:Hari Bala joined Solventum as Chief Technology Officer, Health Information Systems, in May 2025, bringing more than 25 years of experience building large-scale, distributed systems across healthcare, cloud, and security, with deep expertise in GenAI, data science, analytics, and machine learning. Previously, he led AI, data, analytics, and cloud transformation efforts at GE Healthcare and Oracle Cerner, where he helped establish Oracle's AI Services organization and later led the Health Data Intelligence and Analytics platform following the Cerner acquisition. Earlier, Hari spent nearly 19 years at Microsoft in leadership roles spanning Azure, Search, Cosmos DB, Windows, Office 365, and mobile and browser technologies.

Host Dr. Linda Chu speaks with Dr. Jana Ivanidze and Dr. Rajiv Magge about how molecular imaging is transforming the diagnosis and management of breast cancer brain metastases, with an emphasis on precision and personalized care. Their discussion highlights emerging tools such as advanced PET techniques and liquid biopsy that support earlier detection, guide treatment planning, and shape the future of neuro-oncology. Sponsored by GE HealthCare.      

At a recent Crain's event, hospital CEOs warned of fraying health care safety nets in the year ahead. Crain's health care reporter Jon Asplund talks with host Amy Guth about where local health care leaders say they are planning their focus in the year ahead.Plus: Feds warn CTA to boost policing or lose transit funding, Mars wins unconditional EU nod for $36B Kellanova deal, United Airlines CEO Kirby nets nearly $13M in first big stock sale and GE HealthCare touts slate of new tech plus collaboration with Mayo Clinic. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Desiree Chappell and Sol Aronson discuss innovations in anesthesia at ANESTHESIOLOGY® 2025 with Brandon Henak, Global Marketing Director, Monitoring Solutions at GE Healthcare and John W Beard, Chief Medical Officer at GE Healthcare - Patient Care Solutions. They unveil GE's new premium anesthesia platform designed for both current and future needs, emphasizing enhanced workflow, patient safety, and adaptable technology. The conversation highlights the platform's advanced features, including a dual compute architecture, innovative vaporization system, and digital solutions for improved perioperative care. Find out more here: https://www.gehealthcare.co.uk/products/perioperative-care/carestation-850 Listen to more of John W Beard here: https://topmedtalk.libsyn.com/cost-savings-through-continuous-vital-sign-monitoring-anes23 And find more of Brandon Henak here: https://topmedtalk.libsyn.com/tom-westrick-and-brandon-henak-from-ge-healthcare-topmedtalk

Send us a textGood morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we'll explore the latest advances and strategic moves shaping the industry, providing you with insights into how these developments might influence drug development and patient care.The pharmaceutical and biotech sectors are currently experiencing a wave of transformative changes. A significant development is the trade agreement between the United States and the United Kingdom, which excludes medicines from import tariffs. This strategic move, orchestrated by the Trump administration, is set to reduce costs and bolster investments in pharma sectors across both nations. By enhancing market accessibility, it aims to stimulate cross-border investment in pharmaceutical research and production.On the clinical front, Eli Lilly is making headlines by joining Novo Nordisk in reducing self-pay prices for its GLP-1 receptor agonist, Zepbound. This reflects a broader industry trend towards patient-centric pricing models aimed at improving affordability. With healthcare costs on the rise, these measures could ease financial burdens for patients requiring long-term medication regimens.Regulatory updates are also making waves, with the FDA planning stricter vaccine regulations under Dr. Vinay Prasad's leadership at the Center for Biologics Evaluation and Research (CBER). These updates come amid concerns over vaccine safety during COVID-19-related incidents, underscoring a commitment to maintaining public trust in vaccines. Regulatory scrutiny continues as Prasad focuses on COVID-19 vaccine safety in children amid reports linking 10 child deaths to vaccines via VAERS—emphasizing challenges interpreting safety data while highlighting the need for robust methodologies ensuring reliable causality conclusions.In corporate restructuring news, Valneva is streamlining its operations by closing a site and eliminating 30 roles. This move highlights an industry focus on optimizing resources to bolster vaccine development pipelines. Meanwhile, Microsize and Schedio's acquisition of Lonza's Swiss micronization plant underscores ongoing investments in advanced manufacturing technologies critical for high-quality pharmaceuticals.In ophthalmology, Belite Bio is advancing with promising Phase 3 results for tinlarebant in treating Stargardt disease—a rare genetic eye disorder. This success positions Belite to file for FDA approval, potentially expanding treatment options for this underserved patient population. Such advancements in targeted therapies emphasize the need for ongoing research in genetic disorders.Regeneron is betting $150 million on Tessera's gene writing technology targeting alpha-1 antitrypsin deficiency (AATD). This collaboration highlights the industry's growing interest in gene therapy as a frontier for treating rare diseases, marking a shift towards precision medicine where tailored genetic interventions offer hope for previously untreatable conditions. Regeneron's strategic move investing $275 million partnering with Tessera exploring gene editing capabilities—focusing on TSRA-196 targeting the SERPINA1 gene linked to AATD showcases potential advancing therapeutic options for genetic disorders through gene editing technologies offering new disease treatment avenues.AI-driven platforms were spotlighted at RSNA 2025 by industry leaders such as GE Healthcare, Philips, and Siemens. These innovations promise to revolutionize radiological workflows by enhancing diagnostic accuracy and operational efficiency through AI integration. As AI continues to permeate healthcare technologies, its potential to transform diagnostic processes marks a significant leap towards personalized medicine.Akebia Therapeutics' acquisition ofSupport the show

This week, we're diving into a flurry of major M&A activity from GE's $2.3B healthcare tech acquisition to Violia's $3B hazardous waste deal and a massive offshore wind farm stake sale by Denmark's Ørsted. But the spotlight is on Warner Bros. Discovery, where a high-stakes bidding war is heating up.With Paramount, Netflix, and Comcast all circling, Anthony and Piers unpack why the media giant rejected multiple multi-billion dollar offers and how strategic tension is being used to push up valuations. Is splitting the company more valuable than selling it whole? And what's the endgame for each suitor?(00:00) Rate Cut Hopes & Market Moves(07:34) M&A Roundup: Paint, Healthcare & Waste(10:27) Wind Power Play: Ørsted & Apollo(12:39) Warner Bros vs Paramount(24:34) Netflix & Comcast Join the Fray(32:00) Who Buys the Crown Jewels

Send us a textFew people enter the MedTech world because of a personal experience with the technology itself—but for Brent Lavin, that's exactly where it began. At just 23 years old, a CT scan that revealed an urgent medical issue also sparked a lifelong passion for medical technology and its power to save lives. That moment became the foundation of a career devoted to driving innovation in healthcare.Brent's early engineering work revealed an exceptional talent for connecting technical possibility with human need. Over the next two decades, he would lead cross-functional teams through more than 20 successful product launches, three mergers and acquisitions, and hundreds of millions of dollars in portfolio growth. His leadership—marked by curiosity, clarity, and conviction—has earned him accolades such as BD's Director of the Year and the CEO Excellence Award.Today, as Director of Strategic Growth at BD, Brent is responsible for identifying high-impact opportunities for both organic development and targeted acquisitions. Previously, he served as Director of Marketing and Product Management, where he led global teams across multiple disease states to record-breaking revenue growth, even in the face of pandemic-era supply chain challenges.Before joining BD, Brent spent years at GE Healthcare, where he honed his product management and global commercialization expertise, launching next-generation ultrasound systems that achieved over 200% year-over-year growth. His career reflects a rare blend of technical grounding, marketing strategy, and human-centered leadership—built on a mission to deliver meaningful innovation to clinicians and patients worldwide.Beyond the numbers, Brent is known for building high-performing teams and mentoring leaders who thrive in complex environments. Whether he's shaping go-to-market strategies, integrating newly acquired companies, or guiding engineers toward greater clarity and impact, his approach is grounded in purpose: to help people and teams reach their full potential while bringing life-changing technologies to market. LINKS:Guest LinkedIn: https://www.linkedin.com/in/brent-lavin/ Aaron Moncur, hostDownload the Essential Guide to Designing Test Fixtures: https://pipelinemedialab.beehiiv.com/test-fixtureAbout Being An Engineer The Being An Engineer podcast is a repository for industry knowledge and a tool through which engineers learn about and connect with relevant companies, technologies, people resources, and opportunities. We feature successful mechanical engineers and interview engineers who are passionate about their work and who made a great impact on the engineering community. The Being An Engineer podcast is brought to you by Pipeline Design & Engineering. Pipeline partners with medical & other device engineering teams who need turnkey equipment such as cycle test machines, custom test fixtures, automation equipment, assembly jigs, inspection stations and more. You can find us on the web at www.teampipeline.us

O'Hare air traffic has finally topped pre-pandemic levels and appears on track to break a record this year. Crain's aviation reporter John Pletz discusses with host Amy Guth.Plus: One of downtown's biggest distressed loans goes up for sale, Chicago Fed's Goolsbee says he's uneasy about "front loading" rate cuts, GE HealthCare to buy Intelerad for $2.3 billion in cash and feds accuse Chicago crypto firm and its CEO of laundering $10 million. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send us a textIn the final episode of our Rethinking Phototherapy series, Ben speaks with Steve Falk, Chief Engineer of the Maternal Infant Care Strategic Business Unit at GE Healthcare. With more than three decades of engineering leadership, Steve has been instrumental in the development of landmark neonatal technologies, including the Giraffe Omnibed and Panda platforms.This conversation highlights the critical role of engineering in making phototherapy precise, reliable, and safe. Steve explains how advances in LED technology have transformed phototherapy devices, ensuring consistent irradiance and long product life. He describes how engineers translate clinical needs—wavelength, intensity, surface coverage, and distance—into product requirements, and how rigorous usability testing with clinicians shapes intuitive bedside tools. The discussion also explores innovation on the horizon, from refining intermittent phototherapy strategies to integrating technologies that simplify care and support earlier discharge.Listeners will gain a behind-the-scenes perspective on how engineering teams think about phototherapy as a true pharmacotherapy, and how collaboration between clinicians and industry can directly improve outcomes for newborns and families. This episode closes the series by reminding us that innovation in neonatal care happens not only in clinical practice, but also in the design labs where these essential tools are created.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Trust is the foundation for successfully integrating AI into healthcare systems. In this episode, Dr. Taha Kass-Hout, Global Chief Science and Technology Officer at GE Healthcare, shares how AI is transforming operational efficiency, clinical workflows, and patient outcomes across health systems. He highlights applications such as ambient AI for documentation, AI-driven hospital operations, and unified data infrastructures that ease clinicians' cognitive load. Through GE Healthcare's CareIntellect platform and collaborations with systems like HCA, Duke Health, and Queen's Health, hospitals have achieved measurable improvements, including a 22% boost in patient transfers and $20 million in savings. Dr. Kass-Hout also emphasizes the importance of trust, interoperability, and clinician co-design to ensure AI adoption is ethical, scalable, and effective. Tune in and learn how AI-powered infrastructure and trust-driven innovation are redefining the future of healthcare delivery! Resources Connect with and follow Taha Kass-Hout on LinkedIn. Follow GE Healthcare on LinkedIn and explore their website! Listen to Taha's previous episode on the podcast here Browse the GE Healthcare Research website.

if you have any feedback, please send us a text! Thank you!Dr. J.W. Beard, a UCSF-trained anesthesiologist and Chief Medical Officer of GE Healthcare's Patient Care Solutions division, joins the Vital Times podcast to discuss his remarkable career journey. As a member of the Board of the Anesthesia Patient Safety Foundation, Dr. Beard shares how his background in anesthesiology uniquely prepared him for leadership in the medical technology industry, and offers insights into bridging clinical practice and innovation. 

Max Milz is Group Vice President Connected Technology Solutions at Dentsply Sirona, leading its digital healthcare portfolio, which includes imaging, CAD/CAM, surgical equipment, and AI-based clinical software. A passionate tech leader, he previously spent 12 years at Siemens AG, including five years in China. He serves on the Advisory Board of the Value for Good Foundation and holds degrees from Harvard and Cambridge.   David Ferguson joined Dentsply Sirona as Senior Vice President, Global Business Units in March 2025. David Ferguson is a seasoned executive with extensive leadership experience in the medical device and healthcare industries. He has a strong track record of driving revenue growth, strategic transformation, and operational excellence across multiple global businesses. Most recently, he was President of Gore Medical, a unit of W.L. Gore. Previously, as EVP at Philips and President & CEO of Philips Respironics, he managed a global team of 6,000 people. At Baxter Healthcare, he led the global infusion therapy, IV solutions and patient monitoring business. He also held leadership roles at GE Healthcare. Mr. Ferguson is a Graduate of the Advanced Management Program of University of Chicago Booth School of Business and holds a PhD in Chemistry from Texas A&M University and Bachelor of Science in Biochemistry from David Lipscomb University. He has served on multiple boards, including AZBio, Philips PAC, and Baxter International Foundation, and is a co-inventor of two U.S. patents and author of ten peer-reviewed publications.

In this episode of The Lebanese Physicians Podcast, co-hosts Dr. Khalil Diab and Dr. Hamad Ali sit down with Dr. Firas Mahdi, Partner at LEK Consulting in Singapore, to explore the intersection of strategy, technology, and innovation in healthcare across Asia and the Middle East. From his beginnings in clinical medicine at AUBMC to leadership roles at GE Healthcare, Medtronic, and now LEK, Dr. Mahdi shares a remarkable global journey spanning Lebanon, the Gulf, and Southeast Asia. We discuss: How Singapore's hybrid public–private healthcare model achieves world-class outcomes Lessons for Middle Eastern health systems in value-based care and operational excellence The evolving role of MedTech and AI in shaping the future of healthcare Building purpose-driven careers and navigating non-clinical paths in medicine A rich conversation about healthcare transformation, professional reinvention, and the future of global health strategy — where East truly meets Middle East.  

In this episode of the Org Design Podcast, host Tim Brewer and guest cohost Rory Mustan sit down with John Deverill—former British Army lieutenant colonel, ex-GE Healthcare leader, and current NHS change-maker. John shares how the disciplines of military leadership translate into organizational agility, what healthcare can learn from the battlefield, and why most organizations evolve by accident rather than intentional design. From rethinking strategy as “what you actually do,” to building coalitions of the willing, to balancing tradition with innovation, John delivers a masterclass on leading through uncertainty. Whether you're running a hospital, a corporation, or a fast-growing team, this episode will challenge how you think about leadership, strategy, and organizational resilience. John Deverill - https://www.linkedin.com/in/john-deverill-a04a7b1 EODF - https://eodf.eu/ Functionly https://www.linkedin.com/company/functionly https://www.functionly.com/ Org Design Podcast https://www.linkedin.com/company/orgdesignpodcast https://www.functionly.com/org-design-podcast

HR Works Podcast: GE Healthcare on Healing Your People Strategy by HR Daily Advisor

What does it really take to become lean—not just do lean?This is the secret to transformational lean leadership that Larry Culp, CEO of GE and GE Aerospace shared with me on stage three years ago. In this special bonus episode, I want to share his insights and wisdom about leadership and lean culture with you.This bonus episode marks two milestones in my own Chain of Learning® journey: 

Crain's residential real estate reporter Dennis Rodkin joins host Amy Guth to talk news from the local housing market, including Chicago's narrowing lead over U.S. home price growth.Plus: Fed cuts rates quarter point, sets end to balance-sheet runoff, GE HealthCare takes $100 million hit from tariffs, Kraft Heinz lowers sales outlook as CEO warns of worst consumer sentiment in decades and Mondelez also trims outlook, and a developer gets $94 million construction loan for the first phase of its Motorola campus remake.  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

market-moving events. The spotlight is on tech with earnings from heavyweights like Microsoft, Google, Meta, and ServiceNow set to hit after the bell. The Fed announcement and Chair Powell's press conference are front and center today, followed by U.S.–China trade talks at tomorrow's APEC Summit. Markets are leaning into a positive narrative—particularly across the tech sector—while energy, healthcare, and materials trail behind. We'll break down the earnings movers, from CAT and GE Healthcare to CVS and Visa, and what all this means for the market's next move.

Dr. Linda Chu speaks with Dr. Andrew Trout, Professor of Radiology and Director of Clinical Research at Cincinnati Children's, and Dr. Erin Angel, Vice President of Research and Scientific Affairs at GE HealthCare. They discuss the unique challenges of pediatric imaging and how collaboration and technology are advancing care for young patients while improving imaging for all. Sponsored by GE HealthCare.

What does it take to build intelligent systems that are not only AI-powered but also secure, scalable, and grounded in real-world needs? In this episode of Tech Talks Daily, I speak with Srinivas Chippagiri, a senior technology leader and author of Building Intelligent Systems with AI and Cloud Technologies. With over a decade of experience spanning Wipro, GE Healthcare, Siemens, and now Tableau at Salesforce, Srinivas offers a practical view into how AI and cloud infrastructure are evolving together. We explore how AI is changing cloud-native development through predictive maintenance, automated DevOps pipelines, and developer co-pilots. But this is not just about technology. Srinivas highlights why responsible AI needs to be part of every system design, sharing examples from his own research into anomaly detection, fuzzy logic, and explainable models that support trust in regulated industries. The conversation also covers the rise of hybrid and edge computing, the real challenges of data fragmentation and compute costs, and how teams are adapting with new skills like prompt engineering and model observability. Srinivas gives a thoughtful view on what ethical AI deployment looks like in practice, from bias audits to AI governance boards. For those looking to break into this space, his advice is refreshingly clear. Start with small, end-to-end projects. Learn by doing. Contribute to open-source communities. And stay curious. Whether you're scaling AI systems, building a career in cloud tech, or just trying to keep pace with fast-moving trends, this episode offers a grounded and insightful guide to where things are heading next. Srinivas's book is available on Amazon under Building Intelligent Systems with AI and Cloud Technologies, and you can connect with him on LinkedIn to continue the conversation.

A set of AI use cases within the medical space. David Meier, Asit Sharma, and Roland Rott discuss: The latest on GE Healthcare, of which GE Healthcare Imaging is a piece. How AI is used to create efficiency gains, AND How AI is used to boost patient outcomes. Hosts: David Meier and Asit Sharma Guest: Roland Rott Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Shannon Watts is the founder of Moms Demand Action, a prominent grassroots organization fighting gun violence in the United States. She initially aspired to be an investigative journalist, and she earned a journalism degree but transitioned into a career in public relations, spending nearly two decades in corporate communications at companies like Anthem and GE Healthcare. After taking a step back from her career to become a stay-at-home mom, the Sandy Hook tragedy in 2012 spurred her into action, and she founded Moms Demand Action with a simple Facebook group. Leveraging her communications and branding expertise, she transformed the group into a powerful nationwide movement, now part of Everytown for Gun Safety, the largest gun violence prevention organization in the country, with nearly 11 million supporters. She has since been recognized as one of Time's 100 Most Influential People and a Forbes 50 Over 50 Changemaker. She's also authored books including Fight Like a Mother and Fired Up.Buy Shannon's new book here.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.